Have a personal or library account? Click to login
Immunomodulatory Effect of the Bacillus Calmette–Guérin (BCG) Vaccine on the In Vitro Interferon Response Induced by Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigens Cover

Immunomodulatory Effect of the Bacillus Calmette–Guérin (BCG) Vaccine on the In Vitro Interferon Response Induced by Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigens

Archivum Immunologiae et Therapiae Experimentalis
Volume 73 (2025): Issue 1 (January 2025)
By: Magdalena Jurczak,  Joanna Kaczmarek,  Magdalena Kowalewska-Pietrzak and  Magdalena Druszczynska  
Open Access
|Mar 2025
DOI: https://doi.org/10.2478/aite-2025-0007 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: Oct 21, 2024
|
Accepted on: Jan 29, 2025
|
Published on: Mar 18, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Bacillus Calmette–Guérin,
Interferon,
Severe acute respiratory syndrome coronavirus 2,
Respiratory syncytial virus
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2025 Magdalena Jurczak, Joanna Kaczmarek, Magdalena Kowalewska-Pietrzak, Magdalena Druszczynska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2025): Issue 1 (January 2025)Next article